ArticleOpen heart2021

Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors.

James J DiNicolantonio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.